Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BGFV
|
Shane O Starr
Senior VP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct | 1,865 Reduced 9.35% |
$29,243
$15.68 p/Share
|
Mar 18
2022 |
|
BGFV
|
Luke D Thompson
Executive VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 2,526 Reduced 9.79% |
$39,608
$15.68 p/Share
|
Mar 18
2022 |
|
ICVX
|
Cassia Cearley |
BUY
Exercise of conversion of derivative security
|
Direct | 35,137 Added 20.83% |
$29,515
$0.84 p/Share
|
Mar 18
2022 |
|
PLBY
|
Lance Barton
Former CFO |
SELL
Open market or private sale
|
Direct | 66,218 Reduced 9.5% |
$1,034,325
$15.62 p/Share
|
Mar 18
2022 |
|
PLBY
|
Bernhard L Kohn Iii
CEO & President |
SELL
Open market or private sale
|
Direct | 122,000 Reduced 5.47% |
$1,908,080
$15.64 p/Share
|
Mar 18
2022 |
|
PLBY
|
Christopher Riley
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 9.37% |
$343,860
$15.63 p/Share
|
Mar 18
2022 |
|
BBW
|
Eric R Fencl
CAO, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 15,338 Reduced 6.48% |
$286,054
$18.65 p/Share
|
Mar 18
2022 |
|
BBW
|
Eric R Fencl
CAO, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 4,749 Added 1.97% |
$42,029
$8.85 p/Share
|
Mar 18
2022 |
|
AADI
|
Neil Desai |
SELL
Open market or private sale
|
Indirect | 3,550 Reduced 0.19% |
$71,248
$20.07 p/Share
|
Mar 18
2022 |
|
FXLV
|
Mark Wahlberg
Director |
SELL
Open market or private sale
|
Direct | 51,691 Reduced 1.97% |
$691,109
$13.37 p/Share
|
Mar 18
2022 |
|
PRTS
|
Lev Peker
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 115,285 Added 8.8% |
-
|
Mar 18
2022 |
|
PRTS
|
David Meniane
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 64,255 Added 4.97% |
-
|
Mar 18
2022 |
|
PRTS
|
Alfredo Gomez
VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 33,166 Added 5.69% |
-
|
Mar 18
2022 |
|
PRTS
|
Houman Akhavan
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 36,391 Added 7.0% |
-
|
Mar 18
2022 |
|
KODK
|
Kennedy Lewis Investment Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 2,434,179 Added 30.65% |
$14,069,555
$5.78 p/Share
|
Mar 18
2022 |
|
AERI
|
Peter Frederick Lang
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 46,297 Added 50.0% |
-
|
Mar 18
2022 |
|
AERI
|
John La Rocca
General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 19,015 Added 25.92% |
-
|
Mar 18
2022 |
|
AERI
|
Casey C. Kopczynski
Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19,015 Added 6.35% |
-
|
Mar 18
2022 |
|
TRIN
|
Michael Zacharia
Director |
BUY
Open market or private purchase
|
Direct | 1,200 Added 22.09% |
$22,032
$18.36 p/Share
|
Mar 18
2022 |
|
TRIN
|
Ronald E. Estes
Director |
BUY
Open market or private purchase
|
Direct | 600 Added 4.62% |
$10,884
$18.14 p/Share
|
Mar 18
2022 |
|
TRIN
|
Steve Louis Brown
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 1,550 Added 0.3% |
$28,319
$18.27 p/Share
|
Mar 18
2022 |
|
ONEW
|
John Troiano |
SELL
Open market or private sale
|
Indirect | 9,059 Reduced 3.64% |
$366,799
$40.49 p/Share
|
Mar 18
2022 |
|
WW
|
Mindy F Grossman |
SELL
Payment of exercise price or tax liability
|
Direct | 25,771 Reduced 7.64% |
$266,730
$10.35 p/Share
|
Mar 18
2022 |
|
WW
|
Mindy F Grossman |
BUY
Exercise of conversion of derivative security
|
Direct | 71,481 Added 18.35% |
-
|
Mar 18
2022 |
|
ARTNA
|
Pierre A Anderson
Chief Info Officer / Sr VP |
SELL
Open market or private sale
|
Direct | 628 Reduced 100.0% |
$30,144
$48.0 p/Share
|
Mar 18
2022 |
|
OCGN
|
Jessica Crespo
CAO/SVP, Finance |
BUY
Grant, award, or other acquisition
|
Direct | 22,940 Added 36.19% |
-
|
Mar 18
2022 |
|
KZR
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct | 60,000 Added 6.45% |
$988,800
$16.48 p/Share
|
Mar 18
2022 |
|
ANIP
|
Chad Gassert
SVP - CORP. DEV. & STRATEGY |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 1.27% |
$135,750
$27.15 p/Share
|
Mar 18
2022 |
|
LPG
|
Thomas Jason Coleman
Director |
SELL
Open market or private sale
|
Indirect | 800 Reduced 0.02% |
$11,008
$13.76 p/Share
|
Mar 18
2022 |
|
ATEC
|
Craig E Hunsaker
EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct | 66,652 Reduced 4.29% |
$729,173
$10.94 p/Share
|
Mar 18
2022 |
|
ATEC
|
David Sponsel
EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct | 10,582 Reduced 1.61% |
$115,767
$10.94 p/Share
|
Mar 18
2022 |
|
ATEC
|
Brian Snider
EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct | 5,292 Reduced 0.79% |
$57,894
$10.94 p/Share
|
Mar 18
2022 |
|
ATEC
|
Kelli Mari Howell
EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct | 2,940 Reduced 0.54% |
$32,164
$10.94 p/Share
|
Mar 18
2022 |
|
ATEC
|
John Todd Koning
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 10,582 Reduced 3.45% |
$115,767
$10.94 p/Share
|
Mar 18
2022 |
|
CAC
|
David C Flanagan
Director |
BUY
Open market or private purchase
|
Direct | 333 Added 1.74% |
$16,324
$49.02 p/Share
|
Mar 18
2022 |
|
CAC
|
Marie J Mc Carthy
Director |
BUY
Open market or private purchase
|
Direct | 244 Added 4.77% |
$11,961
$49.02 p/Share
|
Mar 18
2022 |
|
CAC
|
Carl John Soderberg
Director |
BUY
Open market or private purchase
|
Direct | 231 Added 0.3% |
$11,324
$49.02 p/Share
|
Mar 18
2022 |
|
CAC
|
Craig N Denekas
Director |
BUY
Open market or private purchase
|
Direct | 244 Added 3.63% |
$11,961
$49.02 p/Share
|
Mar 18
2022 |
|
CAC
|
Lawrence J Sterrs
Director |
BUY
Open market or private purchase
|
Direct | 129 Added 1.68% |
$6,324
$49.02 p/Share
|
Mar 18
2022 |
|
CDRE
|
Brad Williams
PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 34,359 Reduced 32.64% |
$860,693
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
Brad Williams
PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 87,000 Added 45.25% |
$2,179,350
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
Blaine Browers
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 21,844 Reduced 28.76% |
$547,192
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
Blaine Browers
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 55,334 Added 42.15% |
$1,386,117
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
William G Quigley Iii
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 7,834 Added 50.0% |
$196,242
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
Hamish Norton
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 7,834 Added 50.0% |
$196,242
$25.05 p/Share
|
Mar 18
2022 |
|
CDRE
|
Nicolas Sokolow
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 11,000 Added 7.42% |
$275,550
$25.05 p/Share
|
Mar 18
2022 |
|
NLST
|
Gail M Sasaki
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 17,335 Reduced 2.82% |
$86,675
$5.0 p/Share
|
Mar 18
2022 |
|
VERV
|
Sekar Kathiresan
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 69,674 Added 12.73% |
$199,964
$2.87 p/Share
|
Mar 18
2022 |
|
DSGN
|
Stella Xu
Director |
SELL
Open market or private sale
|
Indirect | 565,425 Reduced 6.01% |
$11,133,219
$19.69 p/Share
|
Mar 18
2022 |
|
CMCO
|
Appal Chintapalli
President of EMEA & APAC |
SELL
Payment of exercise price or tax liability
|
Direct | 641 Reduced 5.87% |
$27,723
$43.25 p/Share
|
Mar 18
2022 |